文献速递免疫规划传染病防控与疫情报告

挪威青少年血清和唾液中抗A、C、W和Y群脑膜炎奈瑟菌抗体

Antibodies against Neisseria meningitidis serogroups A, C, W and Y in serum and saliva of Norwegian adolescents.
PubMed 文献 · Vaccine · 2023-08-28

这项横断面研究于2018年采集挪威初高中学生血清和唾液,用多重免疫分析检测针对A、C、W、Y群脑膜炎奈瑟菌荚膜多糖抗体。1344名参与者中84.6%未接种四价脑膜炎球菌结合疫苗(MCV4),未接种者各血清群抗体水平均低,仅6.7–20.0%高抗体亚群具杀菌保护水平,作者建议将MCV4纳入国家免疫规划。

要点

  • 未接种MCV4的挪威青少年对各血清群自然抗体水平低。
  • 高抗体亚群中仅6.7–20.0%经血清杀菌抗体检测达保护水平。
  • 作者建议将MCV4纳入青少年国家免疫规划。

核心结论

  • 未接种MCV4的挪威青少年对本土主要致病血清群自然免疫力低,作者建议将MCV4纳入国家免疫规划。

研究设计与样本

  • 横断面研究,2018年采集挪威初高中学生血清和唾液,共纳入1344名参与者,中位年龄16岁(范围12–24)。

主要发现

  • 1344名参与者中60.9%为女性,1137名(84.6%)未接种MCV4。
  • 未接种者血清和唾液中各血清群荚膜多糖特异性抗体浓度均低。
  • 经血清杀菌抗体检测的高抗体亚群中,仅6.7–20.0%达到保护水平。
  • 未接种的MenY携带者血清MenY抗多糖IgG和唾液IgA水平高于非携带者。
  • 使用瑞典鼻烟与血清抗多糖IgG水平较低相关,水烟使用与唾液抗多糖IgG水平较低相关。

关键数值与推荐

  • 原文未报告具体抗体浓度阈值或保护性判定标准。

临床怎么用

  • 作者认为,基于未接种青少年自然免疫力低,建议将MCV4纳入国家免疫规划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The incidence of invasive meningococcal disease (IMD) among Norwegian 16-19-year-olds was 1-7/100,000 in the decade before the COVID-19 pandemic, with serogroup Y (MenY) dominance. In contrast to many other European countries, meningococcal vaccines are not part of the national immunisation program (NIP) in Norway. This cross-sectional study aimed to measure the degree of natural immunity against Neisseria meningitidis among adolescents in Norway to evaluate the need for introducing tetravalent meningococcal conjugate vaccine (MCV4) in the NIP. MATERIALS AND METHODS: Serum and saliva samples were collected from students in upper and lower secondary schools in Norway in 2018. Samples were analysed for meningococcal capsular polysaccharide (PS)-specific antibodies using a bead-based multiplex immunoassay. PS-specific antibody levels were linked to data on meningococcal carriage, vaccination status and risk factors for carriage (assessed with questionnaire) and analysed by linear regression of log transformed concentrations. A subset of samples from unvaccinated individuals was analysed for serum bactericidal antibodies (SBA). RESULTS: A total of 1344 participants, median age 16 years (range 12-24), were included in the study. Overall, 60.9% of the participants were female and 1137 (84.6%) were not vaccinated with MCV4. PS-specific antibody concentrations in serum and saliva were low among unvaccinated individuals for all serogroups and only 6.7-20.0% of the subpopulation with high PS-specific antibodies assessed with SBA had protective levels. Unvaccinated MenY carriers had higher levels of MenY anti-PS IgG in serum and IgA in saliva than those not carrying MenY. Use of Swedish snus was associated with lower anti-PS IgG levels in serum and waterpipe use with lower anti-PS IgG levels in saliva. CONCLUSION: Unvaccinated adolescents in Norway have a low degree of natural immunity against the serogroups of N. meningitidis predominating among cases of IMD in this age group. Therefore, introduction of MCV4 for adolescents in the NIP is recommended.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Watle SV, Børud B, Laake I, et al. Antibodies against Neisseria meningitidis serogroups A, C, W and Y in serum and saliva of Norwegian adolescents. Vaccine. 2023. PMID: 37648606. doi:10.1016/j.vaccine.2023.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。